Increased risk of dementia among patients with overactive bladder treated with an anticholinergic medication compared to a beta‐3 agonist: a population‐based cohort study-Reference-Cited by-同舟云学术

Increased risk of dementia among patients with overactive bladder treated with an anticholinergic medication compared to a beta‐3 agonist: a population‐based cohort study

Published:2020-03-19 Issue:1 Volume:126 Page:183-190
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:BJU Int

Author:

Welk Blayne¹²³^ORCID,McArthur Eric²

Affiliation:

1. Department of Surgery Western University LondonONCanada

2. ICES LondonONCanada

3. Department of Epidemiology and Biostatistics Western University London ON Canada

Funder

Western University

Publisher

Wiley

Subject

Urology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bju.15040

Reference37 articles.

1. Population-Based Survey of Urinary Incontinence, Overactive Bladder, and Other Lower Urinary Tract Symptoms in Five Countries: Results of the EPIC Study

2. Diagnosis and Treatment of Overactive Bladder (Non-Neurogenic) in Adults: AUA/SUFU Guideline Amendment

3. EAU Guidelines on Assessment and Nonsurgical Management of Urinary Incontinence

4. Mirabegron: a review of recent data and its prospects in the management of overactive bladder

5. Comparative Efficacy and Safety of Medical Treatments for the Management of Overactive Bladder: A Systematic Literature Review and Mixed Treatment Comparison

Cited by 76 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Frailty, Specialized Care, and Sociodemographic Factors: Disparities in Oral Pharmacotherapy Class Utilization Among Medicare Part D Beneficiaries With Overactive Bladder in the United States;Urology;2024-09

2. Risk of dementia associated with the use of anticholinergic medications: a review of recent literature;Current Opinion in Urology;2024-08-15

3. Evaluation and management of urinary incontinence in nursing home residents: unique considerations for an at-risk population;Gynecology and Pelvic Medicine;2024-06

4. Assessing the Impact of Overactive Bladder Medications on Cognition;Urogynecology;2024-05-06

5. Letter to the Editor re: Is It Time to Rethink Our Approach to Overactive Bladder Treatment?;Urogynecology;2024-04-23